SG Americas Securities, LLC - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 95 filers reported holding ATHIRA PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q1 2023$49
+28.9%
19,512
+63.6%
0.00%
Q4 2022$38
-99.9%
11,927
-13.3%
0.00%
-100.0%
Q3 2022$41,000
+7.9%
13,756
+10.0%
0.00%
Q2 2022$38,000
-66.7%
12,504
+43.0%
0.00%
-100.0%
Q4 2021$114,000
-37.4%
8,743
-54.8%
0.00%0.0%
Q3 2021$182,00019,3500.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 714,763$2,265,7992.16%
Perceptive Advisors 4,797,278$15,207,3710.43%
Potomac Capital Management, Inc. 80,000$2540.30%
Bristlecone Advisors, LLC 696,629$2,208,3140.27%
TANG CAPITAL MANAGEMENT LLC 485,234$1,538,1920.22%
RA Capital Management 1,881,300$5,963,7210.12%
GSA CAPITAL PARTNERS LLP 270,989$8590.11%
PATHSTONE FAMILY OFFICE, LLC 3,631,080$8,182,6500.07%
Laird Norton Wetherby Trust Company, LLC 130,000$412,1000.06%
Forefront Analytics, LLC 22,350$70,8510.04%
View complete list of ATHIRA PHARMA INC shareholders